A case of fulminant liver failure associated with hepatitis C virus

Hiromitsu Kanzaki, Akinobu Takaki, Takahito Yagi, Fusao Ikeda, Tetsuya Yasunaka, Kazuko Koike, Yasuhiro Miyake, Yoshiaki Iwasaki, Kazuhiro Nouso, Hiroshi Sadamori, Susumu Shinoura, Yuzo Umeda, Ryuichi Yoshida, Masashi Utusmi, Toshiyoshi Fujiwara, Kazuhide Yamamoto

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Fulminant hepatitis due to acute hepatitis C virus (HCV) infection is rarely observed. We present a case study of a 21-year-old male patient who developed HCV-associated fulminant hepatitis after receiving steroid pulse therapy for optic neuritis. Despite daily plasmapheresis, the disease progressed to irreversible liver failure with grade 3 hepatic encephalopathy by the 6th day after symptom onset. The patient received a liver transplant on the 8th day. Serum anti-HCV antibody was negative at that time, but became positive on the 12th day. Positive HCV RNA in the serum at admission was reported after transplantation. Positive changes in anti-HCV antibodies and acute hepatitis with massive necrosis in the histology of the explanted liver indicated fulminant hepatitis due to acute HCV infection. Because of severe hepatitis recurrence, he started 12 months of interferon therapy on the 48th day, and obtained sustained virological response. His anti-HCV antibodies became negative again by 1.5 years after cessation of therapy. HCV genomes recovered from the patient's serum on the 7th and 48th days revealed 2 different clones out of 20 clones with 30 % amino acid difference in hypervariable region 1 of HCV second envelope glycoprotein. One of the 2 clones expanded further after liver transplantation. We conclude that early diagnosis of HCV-associated fulminant hepatitis requires the detection of HCV RNA in the serum. Severe hepatitis recurrence after liver transplantation might occur in patients with fulminant hepatitis due to HCV because of its monoclonal expansion.

Original languageEnglish
Pages (from-to)170-174
Number of pages5
JournalClinical Journal of Gastroenterology
Volume7
Issue number2
DOIs
Publication statusPublished - 2014

Fingerprint

Acute Liver Failure
Hepacivirus
Hepatitis
Hepatitis C Antibodies
Clone Cells
Virus Diseases
Serum
Liver Transplantation
RNA
Recurrence
Optic Neuritis
Plasmapheresis
Hepatic Encephalopathy
Liver
Liver Failure
Interferons
Early Diagnosis
Histology
Glycoproteins
Necrosis

Keywords

  • Fulminant hepatitis
  • HCV

ASJC Scopus subject areas

  • Gastroenterology

Cite this

A case of fulminant liver failure associated with hepatitis C virus. / Kanzaki, Hiromitsu; Takaki, Akinobu; Yagi, Takahito; Ikeda, Fusao; Yasunaka, Tetsuya; Koike, Kazuko; Miyake, Yasuhiro; Iwasaki, Yoshiaki; Nouso, Kazuhiro; Sadamori, Hiroshi; Shinoura, Susumu; Umeda, Yuzo; Yoshida, Ryuichi; Utusmi, Masashi; Fujiwara, Toshiyoshi; Yamamoto, Kazuhide.

In: Clinical Journal of Gastroenterology, Vol. 7, No. 2, 2014, p. 170-174.

Research output: Contribution to journalArticle

Kanzaki, Hiromitsu ; Takaki, Akinobu ; Yagi, Takahito ; Ikeda, Fusao ; Yasunaka, Tetsuya ; Koike, Kazuko ; Miyake, Yasuhiro ; Iwasaki, Yoshiaki ; Nouso, Kazuhiro ; Sadamori, Hiroshi ; Shinoura, Susumu ; Umeda, Yuzo ; Yoshida, Ryuichi ; Utusmi, Masashi ; Fujiwara, Toshiyoshi ; Yamamoto, Kazuhide. / A case of fulminant liver failure associated with hepatitis C virus. In: Clinical Journal of Gastroenterology. 2014 ; Vol. 7, No. 2. pp. 170-174.
@article{739a8ab0aa954f9f97d49315363157df,
title = "A case of fulminant liver failure associated with hepatitis C virus",
abstract = "Fulminant hepatitis due to acute hepatitis C virus (HCV) infection is rarely observed. We present a case study of a 21-year-old male patient who developed HCV-associated fulminant hepatitis after receiving steroid pulse therapy for optic neuritis. Despite daily plasmapheresis, the disease progressed to irreversible liver failure with grade 3 hepatic encephalopathy by the 6th day after symptom onset. The patient received a liver transplant on the 8th day. Serum anti-HCV antibody was negative at that time, but became positive on the 12th day. Positive HCV RNA in the serum at admission was reported after transplantation. Positive changes in anti-HCV antibodies and acute hepatitis with massive necrosis in the histology of the explanted liver indicated fulminant hepatitis due to acute HCV infection. Because of severe hepatitis recurrence, he started 12 months of interferon therapy on the 48th day, and obtained sustained virological response. His anti-HCV antibodies became negative again by 1.5 years after cessation of therapy. HCV genomes recovered from the patient's serum on the 7th and 48th days revealed 2 different clones out of 20 clones with 30 {\%} amino acid difference in hypervariable region 1 of HCV second envelope glycoprotein. One of the 2 clones expanded further after liver transplantation. We conclude that early diagnosis of HCV-associated fulminant hepatitis requires the detection of HCV RNA in the serum. Severe hepatitis recurrence after liver transplantation might occur in patients with fulminant hepatitis due to HCV because of its monoclonal expansion.",
keywords = "Fulminant hepatitis, HCV",
author = "Hiromitsu Kanzaki and Akinobu Takaki and Takahito Yagi and Fusao Ikeda and Tetsuya Yasunaka and Kazuko Koike and Yasuhiro Miyake and Yoshiaki Iwasaki and Kazuhiro Nouso and Hiroshi Sadamori and Susumu Shinoura and Yuzo Umeda and Ryuichi Yoshida and Masashi Utusmi and Toshiyoshi Fujiwara and Kazuhide Yamamoto",
year = "2014",
doi = "10.1007/s12328-014-0454-x",
language = "English",
volume = "7",
pages = "170--174",
journal = "Clinical Journal of Gastroenterology",
issn = "1865-7257",
publisher = "Springer Japan",
number = "2",

}

TY - JOUR

T1 - A case of fulminant liver failure associated with hepatitis C virus

AU - Kanzaki, Hiromitsu

AU - Takaki, Akinobu

AU - Yagi, Takahito

AU - Ikeda, Fusao

AU - Yasunaka, Tetsuya

AU - Koike, Kazuko

AU - Miyake, Yasuhiro

AU - Iwasaki, Yoshiaki

AU - Nouso, Kazuhiro

AU - Sadamori, Hiroshi

AU - Shinoura, Susumu

AU - Umeda, Yuzo

AU - Yoshida, Ryuichi

AU - Utusmi, Masashi

AU - Fujiwara, Toshiyoshi

AU - Yamamoto, Kazuhide

PY - 2014

Y1 - 2014

N2 - Fulminant hepatitis due to acute hepatitis C virus (HCV) infection is rarely observed. We present a case study of a 21-year-old male patient who developed HCV-associated fulminant hepatitis after receiving steroid pulse therapy for optic neuritis. Despite daily plasmapheresis, the disease progressed to irreversible liver failure with grade 3 hepatic encephalopathy by the 6th day after symptom onset. The patient received a liver transplant on the 8th day. Serum anti-HCV antibody was negative at that time, but became positive on the 12th day. Positive HCV RNA in the serum at admission was reported after transplantation. Positive changes in anti-HCV antibodies and acute hepatitis with massive necrosis in the histology of the explanted liver indicated fulminant hepatitis due to acute HCV infection. Because of severe hepatitis recurrence, he started 12 months of interferon therapy on the 48th day, and obtained sustained virological response. His anti-HCV antibodies became negative again by 1.5 years after cessation of therapy. HCV genomes recovered from the patient's serum on the 7th and 48th days revealed 2 different clones out of 20 clones with 30 % amino acid difference in hypervariable region 1 of HCV second envelope glycoprotein. One of the 2 clones expanded further after liver transplantation. We conclude that early diagnosis of HCV-associated fulminant hepatitis requires the detection of HCV RNA in the serum. Severe hepatitis recurrence after liver transplantation might occur in patients with fulminant hepatitis due to HCV because of its monoclonal expansion.

AB - Fulminant hepatitis due to acute hepatitis C virus (HCV) infection is rarely observed. We present a case study of a 21-year-old male patient who developed HCV-associated fulminant hepatitis after receiving steroid pulse therapy for optic neuritis. Despite daily plasmapheresis, the disease progressed to irreversible liver failure with grade 3 hepatic encephalopathy by the 6th day after symptom onset. The patient received a liver transplant on the 8th day. Serum anti-HCV antibody was negative at that time, but became positive on the 12th day. Positive HCV RNA in the serum at admission was reported after transplantation. Positive changes in anti-HCV antibodies and acute hepatitis with massive necrosis in the histology of the explanted liver indicated fulminant hepatitis due to acute HCV infection. Because of severe hepatitis recurrence, he started 12 months of interferon therapy on the 48th day, and obtained sustained virological response. His anti-HCV antibodies became negative again by 1.5 years after cessation of therapy. HCV genomes recovered from the patient's serum on the 7th and 48th days revealed 2 different clones out of 20 clones with 30 % amino acid difference in hypervariable region 1 of HCV second envelope glycoprotein. One of the 2 clones expanded further after liver transplantation. We conclude that early diagnosis of HCV-associated fulminant hepatitis requires the detection of HCV RNA in the serum. Severe hepatitis recurrence after liver transplantation might occur in patients with fulminant hepatitis due to HCV because of its monoclonal expansion.

KW - Fulminant hepatitis

KW - HCV

UR - http://www.scopus.com/inward/record.url?scp=84900332066&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900332066&partnerID=8YFLogxK

U2 - 10.1007/s12328-014-0454-x

DO - 10.1007/s12328-014-0454-x

M3 - Article

C2 - 26183636

AN - SCOPUS:84900332066

VL - 7

SP - 170

EP - 174

JO - Clinical Journal of Gastroenterology

JF - Clinical Journal of Gastroenterology

SN - 1865-7257

IS - 2

ER -